IXA showed overlapping activities with BTZ, although equipotency in T-ALL and AML cell lines was reached at approximately 10-fold higher concentrations than BTZ in the BTZ-sensitive and -resistant cell lines. Here, CASC3 is linked to acute lymphoblastic leukemia.